Biogen's Alzheimer's drug could cost Medicare billions of dollars a year, report finds

Biogen's new Alzheimer's drug, Aduhelm, could cost Medicare billions of dollars a year, according to an analysis by the nonprofit Kaiser Family Foundation.

from Business News https://ift.tt/3v8WrtT
via IFTTT https://ift.tt/eA8V8J